Novacyt Group
http://novacyt.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Novacyt Group
Stock Watch: Dam Cracks After A Trickle Of Failed Pandemic Products
Many of the many biotech companies that raised money to develop and repurpose their molecules to address the pandemic have started to unwind those efforts. What will this mean for the sector’s valuation?
Sir Mene Pangalos Outlines AZ's Trio Of COVID-19 Targets
The diagnostics tie-up with GSK on testing is a near-term move to help the UK get back to normality, the drug major's biopharmaceuticals R&D boss tells Scrip. AstraZeneca's main focus is to develop monoclonal antibodies to tackle 'wave two' of the coronavirus.
Fact File: Coronavirus Medtech And Diagnostic Updates
As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.
COVID-19 Fact File: Global Diagnostic Test Pipeline
Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.
Company Information
- Industry
- Biotechnology
- Distributors
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Cytology
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Lab21, Ltd.
- Primer Design Ltd.
- IT-IS International Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice